Viking Global Investors LP Bridge Bio Pharma, Inc. Transaction History
Viking Global Investors LP
- $31.6 Billion
- Q2 2025
A detailed history of Viking Global Investors LP transactions in Bridge Bio Pharma, Inc. stock. As of the latest transaction made, Viking Global Investors LP holds 18,555,375 shares of BBIO stock, worth $911 Million. This represents 2.54% of its overall portfolio holdings.
Number of Shares
18,555,375
Previous 22,055,375
15.87%
Holding current value
$911 Million
Previous $762 Million
5.08%
% of portfolio
2.54%
Previous 2.55%
Shares
4 transactions
Others Institutions Holding BBIO
# of Institutions
408Shares Held
188MCall Options Held
11.3MPut Options Held
2.2M-
Vanguard Group Inc Valley Forge, PA16.5MShares$809 Million0.01% of portfolio
-
Kohlberg Kravis Roberts & Co. L.P. New York, NY13.3MShares$651 Million22.63% of portfolio
-
Black Rock Inc. New York, NY12.4MShares$611 Million0.01% of portfolio
-
Janus Henderson Group PLC London, X09.28MShares$455 Million0.21% of portfolio
-
Farallon Capital Management LLC San Francisco, CA7.9MShares$388 Million1.53% of portfolio
About BridgeBio Pharma, Inc.
- Ticker BBIO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 148,246,000
- Market Cap $7.28B
- Description
- BridgeBio Pharma, Inc. engages in the discovery, development, and delivery of various medicines for genetic diseases. The company has a pipeline of 30 development programs that include product candidates ranging from early discovery to late-stage development. Its products in development programs include AG10 and BBP-265, a small molecule stabili...